Johnson & Johnson Raises 2026 Adjusted EPS View
Johnson & Johnson raised its 2026 adjusted EPS view to $11.05–$11.15, from $10.96–$11.11.
Story updates
10:20:20 AM UTC
SquawkNews
Johnson & Johnson (NYSE:JNJ) today announced results for third-quarter 2026.“Johnson & Johnson’s strong third-quarter performance and increased sequential growth reflect the accelerating momentum of our focused portfolio,” said Joaquin Duato, Chairman and Chief Executive Officer. “In the third quar…
10:20:28 AM UTC
SquawkNews
Johnson & Johnson Now Sees 2026 Adj. Operational Sales Growth in Range of 6.4%-6.8% Vs Prior View 6.2%-6.8% >JNJ
10:20:28 AM UTC
SquawkNews
Johnson & Johnson Now Sees 2026 Operational Sales of $100.5B-$100.9B Vs Prior View $100.3B-$100.9B >JNJ
10:20:29 AM UTC
SquawkNews
Johnson & Johnson Now Sees 2026 Adjusted Operational EPS $10.95-$11.05 Vs Prior View $10.86-$11.01 >JNJ
10:22:08 AM UTC
SquawkNews
Johnson & Johnson (NYSE: JNJ ) raises FY2026 Adj EPS guidance from $10.96-$11.11 to $11.05-$11.15 vs $11.08 analyst estimate. Raises FY2026 sales outlook from $100.800 billion-$101.400 billion to $101.000 billion-$101.400 billion vs $101.296 billion estimate.